Clinical Trials in Atlanta

Showing 1221-1240 of 19,805 trials

A Study to Evaluate the Safety and Antiviral Activity of Two Human Monoclonal Antibodies (VRC07-523LS and PGT121.414.LS) During Analytic Treatment Interruption in Participants Living With HIV Who Initiated ART During Acute/Early HIV-1 Infection

NCT06987318

The purpose of this study is to evaluate the safety, tolerability, and efficacy of combination broadly neutralizing antibodies (bNAbs), to induce HIV-1 control during analytic treatment interruption (ATI).

HIV-1-infection

National Institute of Allergy and Infectious Diseases (NIAID)40 participantsStarted Jun 2026

Birmingham, Alabama, United States • San Diego, California, United States • Aurora, Colorado, United States +10 more locations

Active Not RecruitingPhase 3< 1 mile

Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

NCT04975997

This is a multicenter, two-stage, randomized, controlled, open-label, Phase 3 study comparing the efficacy and safety of iberdomide in combination with dexamethasone and daratumumab (IberDd) versus daratumumab, bortezomib, and dexamethasone (DVd) in participants with relapsed or refractory multiple myeloma (RRMM).

Multiple Myeloma

Celgene939 participantsStarted Jun 2022

Hot Springs, Arkansas, United States • Cerritos, California, United States • Fountain Valley, California, United States +256 more locations

A Study to Evaluate the Safety and Antiviral Activity of Two Human Monoclonal Antibodies (VRC07-523LS and PGT121.414.LS) During Analytic Treatment Interruption in Participants Living With HIV Who Initiated ART During Acute/Early HIV-1 Infection

Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

Find Trials by Condition in Atlanta

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)

Treatment Free Remission After Combination Therapy With Ruxolitinib Plus Tyrosine Kinase Inhibitors

A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer

Post Market Evaluation of Clinical Safety and Performance of the Fitbone Transport and Lengthening System

S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

ADAPT - A Patient Registry of the Real-world Use of Orenitram®

A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUGANO) Primary Efficacy Will be Determined at Week 56

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

Biomarker and Edema Attenuation in IntraCerebral Hemorrhage (BEACH)

Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma

Cryoprobe Versus Forceps for Transbronchial Biopsy

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies

A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Fenfluramine (Hydrochloride) in Infants 1 Year to Less Than 2 Years of Age With Dravet Syndrome

Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A

Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)

Lung Ultrasound for Guiding Antibiotic Use in Pediatric Pneumonia